BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk
Bronchogen, tuotekuva
Bioregulators

Bronchogen

Bioregulators

  • Lähetetään Saksasta

Tilaus

Kappalehinta - Ilmainen toimitus Saksaan yli 200 €:n tilauksille Black Weeksin aikana
  • DHL seurannalla
  • Huomaamaton pakkaus

4.6/5 Trustpilotissa73 arvostelua

Yhdellä silmäyksellä

Bronchogen lukuina

Tietopankkimme keskeiset luvut.

Koko tietopankkiartikkeli
Class
Short bioregulator peptideKhavinson cytogen
Use
Subcutaneousin mg
Sizes
20 mg1 size in the shop

Tuotteelle Bronchogen ei ole vielä laboratorioanalyysia. Äänestä sitäTestauta itse, me maksamme puoletKaikki laboratorioanalyysit

Tietoa

Kaikki aiheesta Bronchogen

Tilaa samalla

Mitä tarvitset sen kanssa

Bakteriostaattinen vesi lisätään ostoskoriisi automaattisesti. Ruiskut ja pyyhkeet yhdellä napsautuksella.

Insuliiniruiskut

10 kpl · 5.50 €

Alkoholipyyhkeet

50 kpl · 10 €

Kuinka paljon vettä?

Ruiskun yksiköt injektiopullosi koolle.

Avaa laskuri →

FAQ

Usein kysyttyä

Lähteet jokaiseen vastaukseen: tietopankkiartikkeli

Onko sinulla vielä kysyttävää?

Kirjoita meille, tiimimme auttaa sinua.

Is Bronchogen approved or studied in humans?

As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Bronchogen. A review by the Khavinson group mentions use in lung diseases, but this is not backed by registered, independently checked trials. All data shown here come from cell cultures, DNA experiments and rats.

What is Bronchogen made of?

Of four amino acids: alanine, glutamic acid, aspartic acid and leucine, AEDL for short. The molecular formula is C18H30N4O9. Two papers from the same group write the sequence as Ala-Asp-Glu-Leu, the reviews and PubChem list Ala-Glu-Asp-Leu.

What did the rat model show?

Rats repeatedly breathed nitrogen dioxide for 60 days, a model of COPD. Then they received Bronchogen for one month. The typical remodelling receded: fewer goblet cells and less squamous lining, fewer lymphocytes and less over-inflation. The ciliated cells returned. There was more secretory IgA and fewer signs of inflammation by neutrophils.

What happens in cell cultures?

In cultures from human embryonic bronchial tissue Bronchogen raised cell maturation factors such as CXCL12 and Hoxa3, more so in aged cultures. A second paper found more Ki67 and Mcl-1 (cell division) and changed activity of genes such as NKX2-1, FOXA1, FOXA2 and MUC5AC, which matter for the bronchial lining.

How is such a short peptide supposed to work?

The Khavinson group assumes that short peptides reach the cell nucleus and bind to DNA. In the test tube the melting point of DNA rose by 3.1 degrees with Bronchogen, in another paper it preferred stretches with the sequence CTG. On the computer Bronchogen fits into the transporters PepT1 and LAT1 of the cell membrane. Whether this happens in the body has not been shown.

Which side effects are known?

There are no solid data because Bronchogen has never been tested in a registered human trial. Statements about good tolerability come from the research group itself.

Who researches Bronchogen?

Almost exclusively the group around Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology and its partners. Independent confirmation by other labs is still missing.

Liittyvät

Samankaltaiset tuotteet